These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8443455)

  • 1. [Plasminogen activator and PAI. Detection in aqueous humor of the human eye].
    Steinkamp GW; Hattenbach LO; Heider HW; Scharrer I
    Ophthalmologe; 1993 Feb; 90(1):73-5. PubMed ID: 8443455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor].
    Giedrojć J; Stankiewicz A; Walkowiak M; Galar M; Bielawiec M
    Klin Oczna; 1996; 98(4):283-5. PubMed ID: 9463119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract].
    Kotschy M; Kałuzny J; Kaniasty M; Zekanowska E; Kropińska E
    Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased basal levels of free plasminogen activator activity found in human aqueous humor.
    Wang Y; Taylor DM; Smalley DM; Cone RE; O'Rourke J
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3561-6. PubMed ID: 8056534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator activity in human aqueous humor.
    Smalley DM; Fitzgerald JE; Taylor DM; Cone RE; O'Rourke J
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):48-53. PubMed ID: 8300363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
    J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
    Wu S; He X
    Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
    Masson C; Angles-Cano E
    Ann Biol Clin (Paris); 1989; 47(5):269-74. PubMed ID: 2500878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator in human aqueous humor.
    Bernatchez SF; Tabatabay C; Belin D
    Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2687-92. PubMed ID: 1639615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M; Miyashita C
    Klin Wochenschr; 1988; 66 Suppl 12():62-7. PubMed ID: 3126347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
    Declerck PJ; Verstreken M; Collen D
    Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
    Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S
    Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
    Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome.
    Ullbro C; Kinnby B; Lindberg P; Matsson L
    J Clin Periodontol; 2004 Sep; 31(9):708-12. PubMed ID: 15312091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.